Grail

Grail Expands Blood Test to Symptomatic Patients, Aims to Revolutionize Cancer Diagnosis
Grail Expands Blood Test to Symptomatic Patients, Aims to Revolutionize Cancer Diagnosis
BioSpace
Grail
diagnostics
Medtech
Galleri
cancer
Flag link:
Icahn pushes for spinoff of Illumina’s Grail division
Icahn pushes for spinoff of Illumina’s Grail division
BioPharma Dive
Illumina
Grail
Carl Icahn
M&A
spinoffs
Medtech
diagnostics
Flag link:
Why won’t Illumina sell Grail?
Why won’t Illumina sell Grail?
Medtech Dive
Illumina
M&A
Grail
Carl Icahn
Flag link:
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
CNBC
FTC
Illumina
Grail
competition
M&A
diagnostics
Flag link:
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
CNBC
Illumina
Carl Icahn
Grail
M&A
Flag link:
Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail
Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail
BioPharma Dive
Illumina
Grail
M&A
Medtech
diagnostics
Carl Icahn
Flag link:
Illumina Responds to Icahn Partners' Nomination of Directors
Illumina Responds to Icahn Partners' Nomination of Directors
BioSpace
Illumina
Carl Icahn
M&A
Grail
Flag link:
Carl Icahn takes proxy fight to Illumina: report
Carl Icahn takes proxy fight to Illumina: report
Endpoints
Illumina
Grail
M&A
Carl Icahn
Flag link:
Illumina Could Face Hefty Fine Over Grail Acquisition
Illumina Could Face Hefty Fine Over Grail Acquisition
Medical Devices and Diagnostics Industry
Illumina
Grail
M&A
antitrust
Europe
diagnostics
Medtech
Flag link:
Illumina loses its grip: the sequencing giant’s acquisition of Grail is heading for the rocks
Illumina loses its grip: the sequencing giant’s acquisition of Grail is heading for the rocks
EP Vantage
Illumina
M&A
Grail
Flag link:
Esmo 2022 – Galleri’s real-world exhibition disappoints
Esmo 2022 – Galleri’s real-world exhibition disappoints
EP Vantage
ESMO
Grail
Illumina
diagnostics
multi-cancer test
Galleri
Flag link:
Illumina’s hold on Grail depends now on separate appeals in US, Europe
Illumina’s hold on Grail depends now on separate appeals in US, Europe
BioSpace
Illumina
Grail
M&A
Europe
Flag link:
EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case
EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case
Endpoints
Europe
Illumina
Grail
FTC
M&A
Flag link:
Illumina defeats F.T.C. in major antitrust case
Illumina defeats F.T.C. in major antitrust case
NY Times, NY
Illumina
FTC
Grail
M&A
antitrust
Flag link:
7 of the Most Shocking M&A Rumors in Medtech
7 of the Most Shocking M&A Rumors in Medtech
Medical Devices and Diagnostics Industry
Medtech
M&A
DexCom
Insulet
Medtronic
LivaNova
Baxter
Hill-Rom
Stryker
Boston Scientific
Illumina
Grail
Guardant Health
NeoGenomics
Smith & Nephew
Flag link:
Can Illumina Hold on to Grail?
Can Illumina Hold on to Grail?
Medical Devices and Diagnostics Industry
Illumina
Grail
M&A
Europe
antitrust
Flag link:
EC’s Investigation into Illumina/Grail Merger Isn’t Stopping Anytime Soon
EC’s Investigation into Illumina/Grail Merger Isn’t Stopping Anytime Soon
Medical Devices and Diagnostics Industry
Illumina
Grail
Europe
M&A
Flag link:
Illumina loses challenge to block EU antitrust probe into $8B Grail buyout
Illumina loses challenge to block EU antitrust probe into $8B Grail buyout
Endpoints
Illumina
M&A
Grail
Europe
antitrust
Flag link:
Prepping for FDA approval, Grail is partnering with health systems to validate its pan-cancer test
Prepping for FDA approval, Grail is partnering with health systems to validate its pan-cancer test
MedCity News
Grail
diagnostics
Medtech
pan cancer test
Galleri
Flag link:
The 12 Top Biotech Companies Hiring Now
The 12 Top Biotech Companies Hiring Now
BioSpace
biotech
life sciences
hirings
Regeneron
Pfizer
Amgen
AbbVie
Moderna Therapeutics
CSL Behring
Waters Corporation
Daiichi Sankyo
Gilead Sciences
Grail
Emergent BioSolutions
resilience
Flag link:

Pages